Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

AI-Based Video Analysis for Motor Development Assessment in Children (AMD-AI)

15 mei 2026 bijgewerkt door: Abdullah Furkan Cangi, Medipol University

Development and Validation of an Artificial Intelligence-Based System for Assessing Motor Development in Children Using Video Analysis

This is a non-interventional, prospective observational study aimed at developing and validating an artificial intelligence-based system for assessing motor development in children using video analysis. Children aged 5 to 10 years will perform standardized motor tasks, which will be recorded under controlled conditions. The recorded videos will be analyzed using computer vision and deep learning techniques to extract movement patterns.

The results of the AI-based analysis will be compared with standardized motor assessment scores obtained from the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition - Short Form (BOT-2 SF). Participants will be classified into typical and atypical motor development groups based on BOT-2 scores. The primary objective is to evaluate the classification performance of the AI model. Secondary analyses will examine the relationship between AI predictions and continuous motor performance scores.

The study is designed to explore whether motor development can be assessed objectively without direct clinical testing, using only short video recordings. The findings may contribute to the development of scalable and accessible digital screening tools for early identification of motor development differences in children.

Studie Overzicht

Gedetailleerde beschrijving

This study is a prospective, non-interventional observational study conducted to develop and validate an artificial intelligence-based system for the assessment of motor development in children. The study includes children aged between 5 and 10 years who have no previously diagnosed neurological, developmental, or orthopedic disorders.

All participants will complete the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition - Short Form (BOT-2 SF), which will serve as the reference standard for motor performance. Based on BOT-2 scores, participants will be categorized into typical and atypical motor development groups using predefined thresholds derived from normative data and statistical distribution methods.

In addition to standardized testing, participants will perform a series of structured motor tasks, including jumping jacks, tandem walking, skipping, single-leg balance, finger-to-nose coordination, and protective extension responses. These tasks will be recorded using high-resolution video under controlled environmental conditions.

Video data will be processed using computer vision pipelines. Skeletal keypoints will be extracted using pose estimation models, and silhouette segmentation will be obtained using deep learning-based segmentation models. Extracted features will be normalized and used as input for machine learning and deep learning architectures, including transformer-based models and graph-based networks.

The primary outcome is the classification performance of the AI model in distinguishing typical versus atypical motor development profiles, evaluated using metrics such as ROC-AUC, accuracy, sensitivity, specificity, F1-score, and balanced accuracy. Secondary outcomes include regression performance for predicting continuous motor scores, evaluated using MAE, RMSE, and R-squared values.

Inter-rater reliability of expert evaluations will be assessed using intraclass correlation coefficients (ICC). Additional analyses will include error distribution examination and Bland-Altman analysis to assess agreement between AI predictions and standardized test scores.

This study does not involve any intervention, treatment, or risk beyond standard observational procedures. All participants are healthy volunteers, and informed consent will be obtained from parents or legal guardians. The study has been approved by the Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee.

Studietype

Observationeel

Inschrijving (Geschat)

60

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Kind

Accepteert gezonde vrijwilligers

Ja

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

The study population consists of children aged 5 to 10 years recruited from schools and clinical settings. All participants are typically developing individuals without prior diagnoses, and they are evaluated to identify variations in motor development patterns using standardized testing and video-based analysis.

Beschrijving

Inclusion Criteria:

  • Children aged between 5 and 10 years
  • No diagnosed neurological, developmental, or orthopedic disorders
  • Ability to follow verbal instructions
  • Informed consent obtained from parents or legal guardians
  • No prior participation in sensory integration therapy or special education programs

Exclusion Criteria:

  • Diagnosed neurological, developmental, or orthopedic conditions (e.g., autism spectrum disorder, cerebral palsy, epilepsy)
  • Visual or hearing impairments affecting task performance
  • Severe attention or behavioral problems preventing test completion
  • Physical limitations preventing participation in motor tasks

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Cohorten en interventies

Groep / Cohort
Interventie / Behandeling
Typical Motor Development
Children classified as having typical motor development based on BOT-2 scores. This group represents the control group for comparison with atypical motor development profiles.
This study does not include any therapeutic or experimental intervention. The procedures are limited to observational assessment and data collection. Participants perform standardized motor tasks and are video recorded under controlled conditions. No treatment, training, or behavioral modification is applied. The collected data are analyzed using artificial intelligence-based methods to evaluate motor development patterns.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
AI-Based Classification Accuracy of Motor Development
Tijdsspanne: Baseline assessment (Day 1)
Classification accuracy of the artificial intelligence model in distinguishing typical versus atypical motor development based on video analysis, using the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total score as the reference standard. BOT-2 SF scores range from 0 to 88, with higher scores indicating better motor proficiency.
Baseline assessment (Day 1)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Correlation Between AI Predictions and BOT-2 Scores
Tijdsspanne: Baseline assessment (Day 1)
Statistical relationship between artificial intelligence-generated motor development predictions and Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total scores. BOT-2 SF scores range from 0 to 88, with higher scores indicating better motor proficiency.
Baseline assessment (Day 1)
Mean Absolute Error of AI-Based Motor Score Prediction
Tijdsspanne: Baseline assessment (Day 1)
Mean absolute error (MAE) of the artificial intelligence model in predicting continuous motor development scores based on video analysis, compared with Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total scores.
Baseline assessment (Day 1)
Root Mean Square Error of AI-Based Motor Score Prediction
Tijdsspanne: Baseline assessment (Day 1)
Root mean square error (RMSE) of the artificial intelligence model in predicting continuous motor development scores based on video analysis, compared with Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total scores.
Baseline assessment (Day 1)
R-Squared Performance of AI-Based Motor Score Prediction
Tijdsspanne: Baseline assessment (Day 1)
Coefficient of determination (R-squared) for the artificial intelligence model in predicting continuous motor development scores based on video analysis, compared with Bruininks-Oseretsky Test of Motor Proficiency, Second Edition Short Form (BOT-2 SF) total scores.
Baseline assessment (Day 1)

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Nuttige links

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 januari 2026

Primaire voltooiing (Geschat)

1 augustus 2026

Studie voltooiing (Geschat)

1 september 2026

Studieregistratiedata

Eerst ingediend

29 april 2026

Eerst ingediend dat voldeed aan de QC-criteria

15 mei 2026

Eerst geplaatst (Werkelijk)

19 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

19 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

15 mei 2026

Laatst geverifieerd

1 mei 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • AMD-2026-01

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren